 Name: ___         Unit No:  ___  Admission Date: ___       Discharge Date:  ___  Date of Birth: ___       Sex:  F  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending: ___.  Chief Complaint: Abdominal pain  Major Surgical or Invasive Procedure: ERCP  History of Present Illness: ___ yo female with h/o tia, htn, hyperlipidemia presenting for repeat ERCP for choledocholithiasis. Patient initially presented in ___ with abd pain after eating a muffin. At ___ she was found to have elevated lft/leukocytosis and ultrasound showed gallstones and cbd dilation to 17mm. She was transferred to ___ for ERCP. Multiple stones were found in the CBD and a sphincterotomy was performed with stent placement. Her symptoms improved and she was discharged on po cipro with planned f/u for repeat ERCP. She had a cholecystectomy at ___ in the interrim. She denies having any pain/nausea/vomiting since her hospitalization.  During ERCP today, the stent was removed and sphincterotomy was extended. Multiple stones were removed from a dilated cbd(14mm).  Currently, she denies any abd pain, nausea and no episodes of emesis.

Pertinent ROS noted above. Rest of ROS wnl  Past Medical History: Hyperlipidemia TIA, on Plavix HTN "Brain bleed" 5 months ago following a fall (pt report) spina bifida  Social History: ___ Family History: Father died of "heart problems" at ___. Mother deceased at age ___, also had heart disease. No h/o gallstones  Physical Exam: Admission exam: Vitals: Temp: 98.3 BP: 121/56 HR: 66 O2: 100RA Gen: Patient lying comfortably on the exam bed nad a+ox3 HEENT: mmm oropharynx clear Neck: supple no cervical lad CV: RRR no m/r/g Pulm: CTAB no w/r/r Abd: soft nt nd bs+ no hepatosplenomegaly. Lap chole scars healing. Ext: no ___ edema good pedal pulses skin: bruising on abd consistent with heparin injection, no rashes, ulcers neuro: cn ___ intact. ___ strength in upper/lower extremities psych: normal affect and mood. answer questions appropriately  Pertinent Results: ___ 01:30PM  UREA N-23* CREAT-0.9 SODIUM-139 POTASSIUM-4.3 CHLORIDE-103 TOTAL CO2-24 ANION GAP-16 ___ 01:30PM  estGFR-Using this ___ 01:30PM  ALT(SGPT)-11 AST(SGOT)-15 ALK PHOS-91 AMYLASE-38 TOT BILI-0.8 DIR BILI-0.2 INDIR BIL-0.6 ___ 01:30PM  LIPASE-19 ___ 01:30PM  WBC-8.0 RBC-4.08* HGB-13.4 HCT-38.1 MCV-93 MCH-32.7* MCHC-35.1* RDW-13.1 ___ 01:30PM  PLT COUNT-310# ___ 01:30PM  ___ PTT-24.6 ___

ERCP report: ___: Procedures: A plastic stent was removed. A sphincterotomy was performed in the 12 o'clock position using a sphincterotome over an existing guidewire. A 12mm CRE balloon was introduced for sphincteroplasty and the diameter was progressively increased to 13.5 mm successfully. Many stones ranging in size from 5 mm to 13 mm were extracted successfully using a balloon catheter. Lithotripsy with a mechanical lithotriptor was performed.   Impression: Stent in the major papilla (stent removal) Previous sphincterotomy in the major papilla Successful cannulation of the bile duct (cannulation) Multiple bile duct stones with severe biliary dilation up to 14 mm.

A sphincterotomy was performed in the 12 o'clock position. A 12mm CRE balloon was introduced for sphincteroplasty and the diameter was progressively increased to 13.5 mm successfully. Many stones ranging in size from 5 mm to 13 mm were extracted successfully using a balloon catheter. Lithotripsy with an mechanical lithotriptor was performed.  (stent removal, sphincterotomy, dilation, stone extraction, lithotripsy) Otherwise normal ercp to third part of the duodenum 

 Brief Hospital Course: ___ yo female with h/o TIA, htn, dyslipidemia with recent admission for cholangitis requiring sphincterotomy/stent placement, returning for repeat ERCP. On admission the stent was removed and sphincterotomy was extended and multiple stones were removed. She tolerated the procedure well with no current abd pain, nausea or emesis. . Choledocholithiasis: Was initially NPO and on unasyn. Diet was advanced in the morning. The patient tolerated a normal diet. She was discharged on 7 days of augmentin. . TIA: Lipitor was continued. Patient was instructed to hold plavix for five days. .

 Medications on Admission: 1. multivitamin   Tablet Sig: One (1) Tablet PO DAILY (Daily). 

2. atenolol 50 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).  3. losartan 50 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).  4. meclizine 12.5 mg Tablet Sig: One (1) Tablet PO Q12H (every 12 hours) as needed for dizzy.  5. cholecalciferol (vitamin D3) 1,000 unit Tablet Sig: One (1) Tablet PO once a day.  6. oxybutynin chloride 10 mg Tablet Extended Rel 24 hr Sig: One (1) Tablet Extended Rel 24 hr PO once a day.  7. Plavix 75mg Plavix is on hold.  8. Lipitor 40 mg Tablet Sig: One (1) Tablet PO once a day.  9. Fish Oil ___ mg Capsule Sig: Two (2) Capsule PO once a day.  10. Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day as 

needed for constipation.  11. senna 8.6 mg Tablet Sig: ___ Tablets PO at bedtime as needed 

for constipation. 

 Discharge Disposition: Home  Discharge Diagnosis: choledocholelithiasis cholelithiasis  Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent.  Discharge Instructions: You were admitted for a repeat ERCP. You had a stent removed and multiple gall stones were removed. You tolerated the procedure well with no current abdominal pain, nausea or vomiting. You tolerated a normal diet on discharge. 

All of your medications remain the same. Please continue to take your medications as directed. After this procedure (ERCP) you should not take your plavix for 5 days. You will take an antibiotic called augmentin for total of 7 days. 

Please do not take aspirin, ibuprofen or plavix for five days.  Followup Instructions: ___ 